Subscribe
And the value of an additional star for physicians and hospitals is…

A Health Podyssey

And the value of an additional star for physicians and hospitals is…

Listen to Health Affairs Editor-in-Chief Alan Weil interview Adam Schwartz, associate professor of orthopedic surgery at the Mayo Clinic College of Medicine and Science, on the fiscal value of an…
January 12, 2021
ADVERTISEMENT
TransferWise

And the value of an additional star for physicians and hospitals is…

For better or worse, online platforms and social media have enabled individuals to publicly post their opinions of businesses online. As a result, business are at the mercy of public feedback, which can have an impact on their success.

Hospitals and physicians are not immune to this trend. The Centers for Medicare and Medicaid Services has pushed the idea of consumerization through price transparency policies and the Five-Star Quality Rating System so that patients can rate their providers, for example.

But what is the actual value of a star rating?

On this episode of A Health Podyssey, Alan Weil interviews Dr. Adam Schwartz, associate professor of orthopedic surgery at the Mayo Clinic College of Medicine and Science, who wrote a research paper with colleagues in the January 2021 issue of Health Affairs on the fiscal value of an additional hospital or physician star rating when choosing a provider for total joint replacement.

While patients’ interpretation of star ratings has been poorly understood historically, Schwartz and his colleagues put forward data to help spur further research to understand the value and trust patients place in publicly reported quality ratings.

Listen to Alan Weill and Adam Schwartz discuss public reporting, quality ratings, and their implications on hospital and physician businesses.

Subscribe: RSS | Apple Podcasts | Google Podcasts | Spotify | Castro | Stitcher

ADVERTISEMENT

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.